Symbols / DYNT
DYNT Chart
About
Dynatronics Corporation, a medical device company, designs, develops, manufactures, markets, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States, Asia, Latin America, the Middle East, and internationally. It offers orthopedic soft bracing products, including cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. The company also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. The company markets its products under the Dynatron, Dynatron Solaris, Bird & Cronin, Hausmann, PROTEAM, and Mammoth brand names. It sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers through a network of independent dealers. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota. On January 9, 2026, Dynatronics Corporation, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Bird & Cronin, Hausmann, PROTEAM, and Mammoth brand names. It sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers through a network of independent dealers. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota. On January 9, 2026, Dynatronics Corporation, along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Minnesota.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 653.18K |
| Enterprise Value | 14.22M | Income | -11.45M | Sales | 26.81M |
| Book/sh | -0.37 | Cash/sh | 0.05 | Dividend Yield | — |
| Payout | 0.00% | Employees | 88 | IPO | Nov 16, 1983 |
| P/E | — | Forward P/E | -0.10 | PEG | — |
| P/S | 0.02 | P/B | — | P/C | — |
| EV/EBITDA | -11.08 | EV/Sales | 0.53 | Quick Ratio | 0.42 |
| Current Ratio | 1.07 | Debt/Eq | 225.55 | LT Debt/Eq | — |
| EPS (ttm) | -1.37 | EPS next Y | -0.39 | EPS Growth | — |
| Revenue Growth | -7.60% | Earnings | 2024-02-07 11:00 | ROA | -7.15% |
| ROE | -127.40% | ROIC | — | Gross Margin | 21.49% |
| Oper. Margin | -1.26% | Profit Margin | -40.04% | Shs Outstand | 16.05M |
| Shs Float | 7.40M | Short Float | 0.39% | Short Ratio | 0.29 |
| Short Interest | — | 52W High | 0.17 | 52W Low | 0.04 |
| Beta | 0.31 | Avg Volume | 4.42K | Volume | 100.00 |
| Target Price | — | Recom | None | Prev Close | $0.04 |
| Price | $0.04 | Change | 0.00% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.04
Latest analyst target
3. DCF / Fair value
$1.24
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.04
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2023-10-09 | down | Ladenburg Thalmann | Buy → Neutral | $4 |
- Dynatronics Corporation Provides Update Regarding Transition to OTC Markets Group - Yahoo Finance Fri, 28 Jun 2024 07
- Dynatronics enters Chapter 7 bankruptcy and liquidation - TipRanks Mon, 12 Jan 2026 08
- Why Is Calidi Biotherapeutics (CLDI) Stock Down 51% Today? - InvestorPlace ue, 16 Apr 2024 07
- Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - TradingView ue, 16 Apr 2024 07
- Thinking about buying stock in Oramed Pharmaceuticals, Mogo, Chiasma, Adaptimmune Therapeutics, or Dynatronics? - Daily Freeman ue, 23 Mar 2021 07
- 6 of the Best Penny Stocks to Snap Up on Robinhood - InvestorPlace Fri, 17 Sep 2021 07
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 2000 | — | — | Stock Award(Grant) at price 0.00 per share. | HOLTZ DAVID B | Director | — | 2025-10-15 00:00:00 | D |
| 1 | 2000 | — | — | Stock Award(Grant) at price 0.00 per share. | ENRIGHT ERIN S. J.D. | Director | — | 2025-10-15 00:00:00 | D |
| 2 | 2000 | — | — | Stock Award(Grant) at price 0.00 per share. | WARD R. SCOTT | Director | — | 2025-10-15 00:00:00 | D |
| 3 | 2000 | — | — | Stock Award(Grant) at price 0.00 per share. | HULETT ANDREW | Director | — | 2025-10-15 00:00:00 | D |
| 4 | 2000 | — | — | Stock Award(Grant) at price 0.00 per share. | HOLTZ DAVID B | Director | — | 2025-01-02 00:00:00 | D |
| 5 | 2000 | — | — | Stock Award(Grant) at price 0.00 per share. | WARD R. SCOTT | Director | — | 2025-01-02 00:00:00 | D |
| 6 | 2000 | — | — | Stock Award(Grant) at price 0.00 per share. | HULETT ANDREW | Director | — | 2025-01-02 00:00:00 | D |
| 7 | 2000 | — | — | Stock Award(Grant) at price 0.00 per share. | ESSIG STUART M | Beneficial Owner of more than 10% of a Class of Security | — | 2024-08-15 00:00:00 | I |
| 8 | 2000 | — | — | Stock Award(Grant) at price 0.00 per share. | HOLTZ DAVID B | Director | — | 2024-08-15 00:00:00 | D |
| 9 | 2000 | — | — | Stock Award(Grant) at price 0.00 per share. | ENRIGHT ERIN S. J.D. | Director | — | 2024-08-15 00:00:00 | D |
Financials
| Line Item | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 949.86K |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.27 |
| NormalizedEBITDA | -976.01K | -3.51M | -2.42M | 295.70K |
| TotalUnusualItems | 0.00 | 3.52M | ||
| TotalUnusualItemsExcludingGoodwill | 0.00 | 3.52M | ||
| NetIncomeFromContinuingOperationNetMinorityInterest | -2.70M | -4.97M | -3.99M | 2.00M |
| ReconciledDepreciation | 1.30M | 1.35M | 1.42M | 1.61M |
| ReconciledCostOfRevenue | 24.90M | 30.46M | 33.67M | 34.91M |
| EBITDA | -976.01K | -3.51M | -2.42M | 3.81M |
| EBIT | -2.28M | -4.86M | -3.85M | 2.21M |
| NetInterestIncome | -418.00K | -118.31K | -147.99K | -215.63K |
| InterestExpense | 418.00K | 118.31K | 147.99K | 215.63K |
| NormalizedIncome | -2.70M | -4.97M | -3.99M | -566.88K |
| NetIncomeFromContinuingAndDiscontinuedOperation | -2.70M | -4.97M | -3.99M | 2.00M |
| TotalExpenses | 34.81M | 45.46M | 49.09M | 51.56M |
| TotalOperatingIncomeAsReported | -2.27M | -4.85M | -4.76M | -3.76M |
| DilutedAverageShares | 3.42M | 3.87M | 3.57M | 3.09M |
| BasicAverageShares | 3.42M | 3.87M | 3.57M | 3.09M |
| DilutedEPS | -1.00 | -1.46 | -1.30 | 0.40 |
| BasicEPS | -1.00 | -1.46 | -1.30 | 0.40 |
| DilutedNIAvailtoComStockholders | -3.43M | -5.66M | -4.73M | 1.21M |
| NetIncomeCommonStockholders | -3.43M | -5.66M | -4.73M | 1.21M |
| PreferredStockDividends | 730.87K | 690.98K | 733.38K | 792.01K |
| NetIncome | -2.70M | -4.97M | -3.99M | 2.00M |
| NetIncomeIncludingNoncontrollingInterests | -2.70M | -4.97M | -3.99M | 2.00M |
| NetIncomeContinuousOperations | -2.70M | -4.97M | -3.99M | 2.00M |
| TaxProvision | 0.00 | 0.00 | 0.00 | -9.98K |
| PretaxIncome | -2.70M | -4.97M | -3.99M | 1.99M |
| OtherIncomeExpense | -6.67K | -3.40K | 911.00K | 5.97M |
| OtherNonOperatingIncomeExpenses | -6.67K | -3.40K | 911.00K | 2.45M |
| SpecialIncomeCharges | 0.00 | 3.52M | ||
| OtherSpecialCharges | -3.52M | |||
| NetNonOperatingInterestIncomeExpense | -418.00K | -118.31K | -147.99K | -215.63K |
| InterestExpenseNonOperating | 418.00K | 118.31K | 147.99K | 215.63K |
| OperatingIncome | -2.27M | -4.85M | -4.76M | -3.76M |
| OperatingExpense | 9.91M | 15.00M | 15.43M | 16.65M |
| SellingGeneralAndAdministration | 9.91M | 15.00M | 15.43M | 16.65M |
| GrossProfit | 7.63M | 10.15M | 10.67M | 12.89M |
| CostOfRevenue | 24.90M | 30.46M | 33.67M | 34.91M |
| TotalRevenue | 32.53M | 40.61M | 44.34M | 47.80M |
| OperatingRevenue | 32.45M | 40.51M | 44.23M | 47.54M |
| Line Item | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| PreferredSharesNumber | 3.35M | 3.35M | 3.35M | 3.35M |
| OrdinarySharesNumber | 5.31M | 4.04M | 3.64M | 3.47M |
| ShareIssued | 5.31M | 4.04M | 3.64M | 3.47M |
| NetDebt | 1.64M | |||
| TotalDebt | 6.69M | 5.65M | 3.84M | 5.08M |
| TangibleBookValue | -3.94M | -1.86M | 2.36M | 5.49M |
| InvestedCapital | 8.30M | 8.88M | 13.72M | 17.55M |
| WorkingCapital | 2.85M | 4.48M | 9.29M | 12.43M |
| NetTangibleAssets | 4.04M | 6.12M | 10.34M | 13.47M |
| CapitalLeaseObligations | 4.57M | 5.65M | 3.83M | 5.07M |
| CommonStockEquity | 6.18M | 8.88M | 13.72M | 17.53M |
| PreferredStockEquity | 7.98M | 7.98M | 7.98M | 7.98M |
| TotalCapitalization | 14.16M | 16.86M | 21.70M | 25.52M |
| TotalEquityGrossMinorityInterest | 14.16M | 16.86M | 21.70M | 25.51M |
| StockholdersEquity | 14.16M | 16.86M | 21.70M | 25.51M |
| RetainedEarnings | -28.91M | -25.48M | -19.82M | -15.09M |
| CapitalStock | 43.07M | 42.34M | 41.51M | 40.60M |
| CommonStock | 35.09M | 34.36M | 33.53M | 32.62M |
| PreferredStock | 7.98M | 7.98M | 7.98M | 7.98M |
| TotalLiabilitiesNetMinorityInterest | 11.78M | 13.21M | 13.74M | 13.63M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 4.08M | 5.27M | 3.80M | 5.15M |
| OtherNonCurrentLiabilities | 189.86K | 201.72K | 206.49K | 203.92K |
| NonCurrentDeferredLiabilities | 626.87K | 777.31K | 927.76K | 1.08M |
| NonCurrentDeferredRevenue | 626.87K | 777.31K | 927.76K | 1.08M |
| LongTermDebtAndCapitalLeaseObligation | 3.26M | 4.29M | 2.67M | 3.87M |
| LongTermCapitalLeaseObligation | 3.26M | 4.29M | 2.67M | 3.87M |
| LongTermDebt | 5.36K | |||
| CurrentLiabilities | 7.70M | 7.94M | 9.94M | 8.47M |
| OtherCurrentLiabilities | 13.74K | 23.97K | 33.19K | |
| CurrentDeferredLiabilities | 150.45K | 150.45K | 150.45K | 150.45K |
| CurrentDeferredRevenue | 150.45K | 150.45K | 150.45K | 150.45K |
| CurrentDebtAndCapitalLeaseObligation | 3.43M | 1.36M | 1.17M | 1.21M |
| CurrentCapitalLeaseObligation | 1.31M | 1.36M | 1.17M | 1.20M |
| CurrentDebt | 2.12M | 5.36K | 13.45K | |
| OtherCurrentBorrowings | 5.36K | 13.45K | ||
| LineOfCredit | 2.12M | 0.00 | 0.00 | |
| CurrentProvisions | 120.68K | 115.64K | 197.16K | 196.71K |
| PayablesAndAccruedExpenses | 4.00M | 6.30M | 8.39M | 6.88M |
| CurrentAccruedExpenses | 1.29M | 1.77M | 2.22M | 3.14M |
| Payables | 2.71M | 4.53M | 6.17M | 3.74M |
| AccountsPayable | 2.71M | 4.53M | 6.17M | 3.74M |
| TotalAssets | 25.94M | 30.06M | 35.43M | 39.14M |
| TotalNonCurrentAssets | 15.38M | 17.64M | 16.21M | 18.23M |
| OtherNonCurrentAssets | 465.50K | 829.05K | 373.74K | 403.92K |
| GoodwillAndOtherIntangibleAssets | 10.12M | 10.73M | 11.36M | 12.05M |
| OtherIntangibleAssets | 3.00M | 3.62M | 4.24M | 4.93M |
| Goodwill | 7.12M | 7.12M | 7.12M | 7.12M |
| NetPPE | 4.80M | 6.08M | 4.48M | 5.78M |
| AccumulatedDepreciation | -5.44M | -4.76M | -4.02M | -3.90M |
| GrossPPE | 10.24M | 10.84M | 8.50M | 9.69M |
| OtherProperties | 2.83M | 3.63M | 1.57M | 2.46M |
| MachineryFurnitureEquipment | 3.27M | 3.25M | 3.02M | 3.31M |
| BuildingsAndImprovements | 4.13M | 3.96M | 3.92M | 3.92M |
| LandAndImprovements | 0.00 | |||
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 10.56M | 12.42M | 19.23M | 20.91M |
| RestrictedCash | 50.41K | 154.07K | 151.21K | 151.20K |
| PrepaidAssets | 530.36K | 701.46K | 590.82K | 1.28M |
| Inventory | 5.59M | 7.40M | 12.07M | 6.53M |
| InventoriesAdjustmentsAllowances | -589.68K | -495.93K | -379.20K | -626.98K |
| FinishedGoods | 2.27M | 3.14M | 5.60M | 2.51M |
| WorkInProcess | 315.07K | 66.36K | 313.55K | 784.46K |
| RawMaterials | 3.60M | 4.69M | 6.54M | 3.86M |
| Receivables | 3.90M | 3.76M | 5.86M | 6.84M |
| OtherReceivables | 454.39K | 39.68K | 446.49K | 1.20M |
| AccountsReceivable | 3.44M | 3.72M | 5.42M | 5.64M |
| AllowanceForDoubtfulAccountsReceivable | -49.00K | -131.40K | -248.22K | -398.89K |
| GrossAccountsReceivable | 3.49M | 3.85M | 5.66M | 6.04M |
| CashCashEquivalentsAndShortTermInvestments | 483.92K | 398.80K | 550.11K | 6.10M |
| CashAndCashEquivalents | 483.92K | 398.80K | 550.11K | 6.10M |
| Line Item | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
| FreeCashFlow | -1.85M | 184.26K | -5.20M | 236.09K |
| RepaymentOfDebt | -286.52K | -332.71K | -350.09K | -426.08K |
| IssuanceOfDebt | 0.00 | |||
| IssuanceOfCapitalStock | 0.00 | 3.46M | ||
| CapitalExpenditure | -243.29K | -186.85K | -317.81K | -146.87K |
| InterestPaidSupplementalData | 276.74K | 244.42K | 148.00K | 184.69K |
| EndCashPosition | 534.33K | 552.87K | 701.32K | 6.25M |
| BeginningCashPosition | 552.87K | 701.32K | 6.25M | 2.32M |
| ChangesInCash | -18.54K | -148.45K | -5.55M | 3.94M |
| FinancingCashFlow | 1.84M | -332.71K | -350.09K | 2.02M |
| CashFlowFromContinuingFinancingActivities | 1.84M | -332.71K | -350.09K | 2.02M |
| NetCommonStockIssuance | 0.00 | 3.46M | ||
| CommonStockIssuance | 0.00 | 3.46M | ||
| NetIssuancePaymentsOfDebt | 1.84M | -332.71K | -350.09K | -1.44M |
| NetShortTermDebtIssuance | 2.12M | 0.00 | 0.00 | -1.01M |
| NetLongTermDebtIssuance | -286.52K | -332.71K | -350.09K | -426.08K |
| LongTermDebtPayments | -286.52K | -332.71K | -350.09K | -426.08K |
| LongTermDebtIssuance | 0.00 | |||
| InvestingCashFlow | -243.29K | -186.85K | -317.81K | 1.53M |
| CashFlowFromContinuingInvestingActivities | -243.29K | -186.85K | -317.81K | 1.53M |
| NetPPEPurchaseAndSale | -243.29K | -186.85K | -317.81K | 1.53M |
| SaleOfPPE | 0.00 | 1.68M | ||
| PurchaseOfPPE | -243.29K | -186.85K | -317.81K | -146.87K |
| OperatingCashFlow | -1.61M | 371.11K | -4.88M | 382.96K |
| CashFlowFromContinuingOperatingActivities | -1.61M | 371.11K | -4.88M | 382.96K |
| ChangeInWorkingCapital | -120.31K | 4.01M | -1.98M | 709.48K |
| ChangeInOtherCurrentAssets | 363.54K | -455.31K | 16.99K | 5.25K |
| ChangeInPayablesAndAccruedExpense | -2.32M | -2.19M | 1.51M | 1.92M |
| ChangeInPayable | -2.32M | -2.19M | 1.51M | 1.92M |
| ChangeInAccountPayable | -2.32M | -2.19M | 1.51M | 1.92M |
| ChangeInPrepaidAssets | -243.61K | 296.18K | 1.45M | -746.22K |
| ChangeInInventory | 1.72M | 4.55M | -5.33M | 492.20K |
| ChangeInReceivables | 359.50K | 1.81M | 377.63K | -963.33K |
| ChangesInAccountReceivables | 359.50K | 1.81M | 377.63K | -963.33K |
| OtherNonCashItems | -150.45K | -150.45K | -137.26K | -126.51K |
| StockBasedCompensation | 1.64K | 131.34K | 178.15K | 154.20K |
| ProvisionandWriteOffofAssets | 11.35K | -96.00 | -398.43K | 273.07K |
| DepreciationAmortizationDepletion | 1.30M | 1.35M | 1.42M | 1.61M |
| DepreciationAndAmortization | 1.30M | 1.35M | 1.42M | 1.61M |
| AmortizationCashFlow | 618.30K | 622.45K | 688.15K | 754.12K |
| AmortizationOfIntangibles | 618.30K | 622.45K | 688.15K | 754.12K |
| Depreciation | 685.41K | 726.39K | 733.65K | 852.67K |
| OperatingGainsLosses | 41.39K | 24.16K | -4.24M | |
| GainLossOnSaleOfPPE | 41.39K | 0.00 | 24.16K | -717.33K |
| NetIncomeFromContinuingOperations | -2.70M | -4.97M | -3.99M | 2.00M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for DYNT
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|